secwatch.observer — SEC 8-K summary
======================================

Issuer:     Niagen Bioscience, Inc. (NAGE)
CIK:        0001386570
Form:       8-K
Filed at:   2022-04-18T23:59:59+00:00
Accession:  0001628280-22-009420
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

ChromaDex announces director retirement and appointment of two new independent directors
--------------------------------------------------------------------------------

- Stephen Block to retire from board at 2022 annual meeting; not due to any disagreement.
- Kristin Patrick appointed to board and Nominating Committee; currently EVP/CMO of Claires, Inc.
- Ann Cohen appointed to board and Audit Committee; EVP/CFO of The Institute of Internal Auditors, CPA.
- Each new director receives 40,000 stock option grant vesting over 3 years, plus annual retainer of $40,000.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1386570/000162828022009420/0001628280-22-009420-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1386570/000162828022009420/cdxc-20220414.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-009420

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer